Geotrypetes seraphini chromosome 18, aGeoSer1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia; Gymnophiona; Geotrypetes.
REFSEQ INFORMATION: The reference sequence is identical to\nLR699163.1.\nAssembly name: aGeoSer1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the SC on 2019/08/18. The\noriginal whole-genome shotgun project has the accession\nCABPRQ000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Geotrypetes seraphini Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.4\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
lysine demethylase 3B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
lysine demethylase 3B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
lysine-specific demethylase 3B isoform X2
lysine-specific demethylase 3B isoform X1
C-terminal-binding protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
C-terminal-binding protein 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
C-terminal-binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
C-terminal-binding protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
C-terminal-binding protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
C-terminal-binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
C-terminal-binding protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
C-terminal-binding protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
oocyte-specific histone RNA stem-loop-binding protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
oocyte-specific histone RNA stem-loop-binding protein 2-like, transcript variant X1
oocyte-specific histone RNA stem-loop-binding protein 2-like isoform X2
oocyte-specific histone RNA stem-loop-binding protein 2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cell division cycle 23, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cell division cycle 23, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cell division cycle protein 23 homolog isoform X1
cell division cycle protein 23 homolog isoform X2
kinesin family member 20A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
kinesin family member 20A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
kinesin family member 20A, transcript variant X1
bromodomain containing 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
bromodomain containing 8, transcript variant X6
bromodomain containing 8, transcript variant X5
bromodomain containing 8, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
bromodomain containing 8, transcript variant X1
bromodomain containing 8, transcript variant X2
bromodomain-containing protein 8 isoform X1
bromodomain-containing protein 8 isoform X4
bromodomain-containing protein 8 isoform X2
bromodomain containing 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
bromodomain-containing protein 8 isoform X3
beta-1,4-galactosyltransferase 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
beta-1,4-galactosyltransferase 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
beta-1,4-galactosyltransferase 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transmembrane emp24 domain-containing protein 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
vesicular integral-membrane protein VIP36
regulator of G protein signaling 14, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
regulator of G protein signaling 14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
regulator of G protein signaling 14, transcript variant X1
regulator of G protein signaling 14, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
regulator of G-protein signaling 14 isoform X1
regulator of G-protein signaling 14 isoform X2
regulator of G-protein signaling 14 isoform X4
regulator of G protein signaling 14, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
regulator of G-protein signaling 14 isoform X3
solute carrier family 34 member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
sodium-dependent phosphate transport protein 2A isoform X2
solute carrier family 34 member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium-dependent phosphate transport protein 2A isoform X1
solute carrier family 34 member 1, transcript variant X5
solute carrier family 34 member 1, transcript variant X3
sodium-dependent phosphate transport protein 2A isoform X3
solute carrier family 34 member 1, transcript variant X4
sodium-dependent phosphate transport protein 2A isoform X4
sodium-dependent phosphate transport protein 2A isoform X5
alpha-2Db adrenergic receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
alpha-2Db adrenergic receptor-like, transcript variant X1
alpha-2 adrenergic receptor-like isoform X2
alpha-2Db adrenergic receptor-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
G protein-coupled receptor kinase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
G protein-coupled receptor kinase 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
G protein-coupled receptor kinase 6 isoform X1
G protein-coupled receptor kinase 6 isoform X2
G protein-coupled receptor kinase 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
G protein-coupled receptor kinase 6 isoform X3
G protein-coupled receptor kinase 6, transcript variant X4
G protein-coupled receptor kinase 6, transcript variant X6
G protein-coupled receptor kinase 6 isoform X4
G protein-coupled receptor kinase 6, transcript variant X5
G protein-coupled receptor kinase 6 isoform X5
proline rich 7, synaptic, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
proline rich 7, synaptic, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
PDZ and LIM domain 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
PDZ and LIM domain 7, transcript variant X2
PDZ and LIM domain 7, transcript variant X1
PDZ and LIM domain 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PDZ and LIM domain 7, transcript variant X8
PDZ and LIM domain 7, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
PDZ and LIM domain 7, transcript variant X4
PDZ and LIM domain 7, transcript variant X7
PDZ and LIM domain 7, transcript variant X6
PDZ and LIM domain 7, transcript variant X9
PDZ and LIM domain 7, transcript variant X12
PDZ and LIM domain 7, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DEAD-box helicase 41, transcript variant X3
DEAD-box helicase 41, transcript variant X1
DEAD-box helicase 41, transcript variant X4
DEAD-box helicase 41, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX41 isoform X4
probable ATP-dependent RNA helicase DDX41 isoform X3
probable ATP-dependent RNA helicase DDX41 isoform X2
probable ATP-dependent RNA helicase DDX41 isoform X1
family with sequence similarity 193 member B, transcript variant X3
family with sequence similarity 193 member B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
family with sequence similarity 193 member B, transcript variant X1
family with sequence similarity 193 member B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
PRELI domain-containing protein 1, mitochondrial
RAB24, member RAS oncogene family, transcript variant X2
RAB24, member RAS oncogene family, transcript variant X1
RAB24, member RAS oncogene family, transcript variant X4
RAB24, member RAS oncogene family, transcript variant X3
nuclear receptor binding SET domain protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear receptor binding SET domain protein 1, transcript variant X1
nuclear receptor binding SET domain protein 1, transcript variant X2
histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific
fibroblast growth factor receptor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fibroblast growth factor receptor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
BRCA1-A complex subunit RAP80-like, transcript variant X1
BRCA1-A complex subunit RAP80-like, transcript variant X2
BRCA1-A complex subunit RAP80-like isoform X1
BRCA1-A complex subunit RAP80-like isoform X2
unc-5 netrin receptor A, transcript variant X3
unc-5 netrin receptor A, transcript variant X4
unc-5 netrin receptor A, transcript variant X2
unc-5 netrin receptor A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
eukaryotic translation initiation factor 4E family member 1B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
eukaryotic translation initiation factor 4E family member 1B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
eukaryotic translation initiation factor 4E type 1B isoform X2
eukaryotic translation initiation factor 4E type 1B isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ring finger protein 44, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ring finger protein 44, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ring finger protein 44, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ring finger protein 44, transcript variant X2
ring finger protein 44, transcript variant X5
ring finger protein 44, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Fas associated factor family member 2, transcript variant X2
Fas associated factor family member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Fas associated factor family member 2, transcript variant X3
HIG1 hypoxia inducible domain family member 2A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
HIG1 domain family member 2A, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
KIAA1191 ortholog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
putative monooxygenase p33MONOX isoform X2
KIAA1191 ortholog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
KIAA1191 ortholog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
putative monooxygenase p33MONOX isoform X1
SUMO-interacting motif-containing protein 1
histamine receptor H2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
histamine receptor H2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine protease inhibitor Kazal-type 1-like
uncharacterized PE-PGRS family protein PE_PGRS54-like, transcript variant X2
uncharacterized PE-PGRS family protein PE_PGRS54-like, transcript variant X3
uncharacterized PE-PGRS family protein PE_PGRS54-like, transcript variant X5
uncharacterized PE-PGRS family protein PE_PGRS54-like, transcript variant X4
uncharacterized PE-PGRS family protein PE_PGRS54-like, transcript variant X1
uncharacterized PE-PGRS family protein PE_PGRS54-like isoform X2
uncharacterized PE-PGRS family protein PE_PGRS54-like isoform X3
uncharacterized PE-PGRS family protein PE_PGRS54-like isoform X5
uncharacterized PE-PGRS family protein PE_PGRS54-like isoform X4
uncharacterized PE-PGRS family protein PE_PGRS54-like isoform X1
predicted GPI-anchored protein 23 isoform X22
spore coat protein SP65-like isoform X23
predicted GPI-anchored protein 23 isoform X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
5-hydroxytryptamine receptor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
5-hydroxytryptamine receptor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
5-hydroxytryptamine receptor 4 isoform X1
5-hydroxytryptamine receptor 4 isoform X2
5-hydroxytryptamine receptor 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
5-hydroxytryptamine receptor 4 isoform X3
phosphodiesterase 6A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphodiesterase 6A, transcript variant X3
phosphodiesterase 6A, transcript variant X6
phosphodiesterase 6A, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphodiesterase 6A, transcript variant X5
rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha isoform X3
solute carrier family 26 member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 26 member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 26 member 2, transcript variant X1
solute carrier family 26 member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphodiesterase 6A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphodiesterase 6A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha isoform X1
rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha isoform X2
rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha isoform X4
PPARG coactivator 1 beta, transcript variant X2
PPARG coactivator 1 beta, transcript variant X1
PPARG coactivator 1 beta, transcript variant X3
peroxisome proliferator-activated receptor gamma coactivator 1-beta isoform X2
peroxisome proliferator-activated receptor gamma coactivator 1-beta isoform X1
Rho guanine nucleotide exchange factor 37, transcript variant X2
Rho guanine nucleotide exchange factor 37, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
rho guanine nucleotide exchange factor 37 isoform X1
Rho guanine nucleotide exchange factor 37, transcript variant X3
rho guanine nucleotide exchange factor 37 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: toll-like receptor 13
casein kinase 1 alpha 1, transcript variant X1
casein kinase 1 alpha 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
casein kinase 1 alpha 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
casein kinase 1 alpha 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
actin filament associated protein 1 like 1
actin filament-associated protein 1-like 1
actin binding LIM protein family member 3, transcript variant X8
actin binding LIM protein family member 3, transcript variant X6
actin binding LIM protein family member 3, transcript variant X3
actin binding LIM protein family member 3, transcript variant X4
actin binding LIM protein family member 3, transcript variant X2
actin binding LIM protein family member 3, transcript variant X1
actin binding LIM protein family member 3, transcript variant X5
actin binding LIM protein family member 3, transcript variant X7
actin binding LIM protein family member 3, transcript variant X10
actin binding LIM protein family member 3, transcript variant X9
SH3 domain and tetratricopeptide repeats 2, transcript variant X1
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X1
SH3 domain and tetratricopeptide repeats 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeats 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeats 2, transcript variant X2
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X2
SH3 domain and tetratricopeptide repeats 2, transcript variant X4
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X3
adrenoceptor beta 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
adrenoceptor beta 2, transcript variant X1
ubiquitin domain containing 2, transcript variant X1
ubiquitin domain containing 2, transcript variant X2
ubiquitin domain-containing protein 2 isoform X1
ubiquitin domain-containing protein 2 isoform X2
serine/threonine kinase 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine/threonine-protein kinase 10 isoform X1
serine/threonine kinase 10, transcript variant X2
serine/threonine-protein kinase 10 isoform X2
SH3 and PX domains 2B, transcript variant X1
SH3 and PX domains 2B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SH3 and PX domains 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SH3 and PX domain-containing protein 2B isoform X1
SH3 and PX domain-containing protein 2B isoform X3
SH3 and PX domain-containing protein 2B isoform X2
neuralized E3 ubiquitin protein ligase 1B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
neuralized E3 ubiquitin protein ligase 1B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neuralized E3 ubiquitin protein ligase 1B, transcript variant X2
E3 ubiquitin-protein ligase NEURL1B isoform X1
E3 ubiquitin-protein ligase NEURL1B isoform X2
E3 ubiquitin-protein ligase NEURL1B isoform X3
endoplasmic reticulum-golgi intermediate compartment 1
endoplasmic reticulum-Golgi intermediate compartment protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CREB3 regulatory factor, transcript variant X2
CREB3 regulatory factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CREB3 regulatory factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
BCL2 interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
vesicle transport protein SEC20 isoform X2
BCL2 interacting protein 1, transcript variant X1
vesicle transport protein SEC20 isoform X1
BCL2 interacting protein 1, transcript variant X3
vesicle transport protein SEC20 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
biorientation of chromosomes in cell division 1, transcript variant X2
biorientation of chromosomes in cell division 1, transcript variant X1
biorientation of chromosomes in cell division protein 1 isoform X1
biorientation of chromosomes in cell division protein 1 isoform X2
cytoplasmic polyadenylation element binding protein 4, transcript variant X1
cytoplasmic polyadenylation element binding protein 4, transcript variant X2
cytoplasmic polyadenylation element-binding protein 4 isoform X1
cytoplasmic polyadenylation element-binding protein 4 isoform X2
neuronal vesicle trafficking associated 2, transcript variant X3
neuronal vesicle trafficking associated 2, transcript variant X2
neuronal vesicle trafficking associated 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neuronal vesicle trafficking-associated protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
janus kinase and microtubule interacting protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
janus kinase and microtubule interacting protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
janus kinase and microtubule-interacting protein 2 isoform X1
janus kinase and microtubule-interacting protein 2 isoform X2
dihydropyrimidinase like 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dihydropyrimidinase-related protein 3 isoform X2
dihydropyrimidinase like 3, transcript variant X5
dihydropyrimidinase like 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dihydropyrimidinase-related protein 3 isoform X3
dihydropyrimidinase like 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dihydropyrimidinase-related protein 3 isoform X1
dihydropyrimidinase like 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dihydropyrimidinase-related protein 3 isoform X4
dihydropyrimidinase-related protein 3 isoform X5
serine/threonine kinase 32A, transcript variant X1
serine/threonine-protein kinase 32A isoform X1
serine/threonine kinase 32A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine/threonine-protein kinase 32A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 2 regulatory subunit Bbeta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
transcription elongation regulator 1, transcript variant X1
transcription elongation regulator 1, transcript variant X2
transcription elongation regulator 1, transcript variant X3
transcription elongation regulator 1 isoform X1
transcription elongation regulator 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins
POU domain, class 4, transcription factor 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
SH3 domain containing ring finger 2, transcript variant X3
SH3 domain containing ring finger 2, transcript variant X5
SH3 domain containing ring finger 2, transcript variant X2
SH3 domain containing ring finger 2, transcript variant X1
SH3 domain containing ring finger 2, transcript variant X4
glutaredoxin and cysteine rich domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
glutaredoxin domain-containing cysteine-rich protein 2
uncharacterized LOC117351887, transcript variant X2
uncharacterized LOC117351887, transcript variant X1
potassium channel tetramerization domain containing 16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
BTB/POZ domain-containing protein KCTD16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC117351549, transcript variant X1
uncharacterized LOC117351549, transcript variant X2
nuclear receptor subfamily 3 group C member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nuclear receptor subfamily 3 group C member 1, transcript variant X1
nuclear receptor subfamily 3 group C member 1, transcript variant X4
nuclear receptor subfamily 3 group C member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Rho GTPase activating protein 26, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Rho GTPase activating protein 26, transcript variant X1
Rho GTPase activating protein 26, transcript variant X4
Rho GTPase activating protein 26, transcript variant X2
rho GTPase-activating protein 26 isoform X4
rho GTPase-activating protein 26 isoform X2
rho GTPase-activating protein 26 isoform X3
rho GTPase-activating protein 26 isoform X1
Rho GTPase activating protein 26, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
rho GTPase-activating protein 26 isoform X6
Rho GTPase activating protein 26, transcript variant X5
rho GTPase-activating protein 26 isoform X5
fibroblast growth factor 1, transcript variant X1
fibroblast growth factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fibroblast growth factor 1, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein sprouty homolog 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glucosamine-6-phosphate deaminase 1, transcript variant X1
glucosamine-6-phosphate deaminase 1, transcript variant X2
glucosamine-6-phosphate isomerase 1 isoform X1
glucosamine-6-phosphate isomerase 1 isoform X2
ring finger protein 14, transcript variant X2
ring finger protein 14, transcript variant X1
E3 ubiquitin-protein ligase RNF14 isoform X1
ring finger protein 14, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF14 isoform X2
heat shock protein family A (Hsp70) member 4
zinc finger CCHC domain-containing protein 10
AF4/FMR2 family member 4, transcript variant X1
AF4/FMR2 family member 4, transcript variant X2
AF4/FMR2 family member 4, transcript variant X3
AF4/FMR2 family member 4, transcript variant X4
cytochrome b-c1 complex subunit 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cytochrome b-c1 complex subunit 8, transcript variant X3
cytochrome b-c1 complex subunit 8, transcript variant X2
cytochrome b-c1 complex subunit 8, transcript variant X4
shroom family member 1, transcript variant X2
shroom family member 1, transcript variant X1
sosondowah ankyrin repeat domain family member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain-containing protein SOWAHA
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 101 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 101 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 101 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC117351751, transcript variant X2
uncharacterized LOC117351751, transcript variant X1
kinesin family member 3A, transcript variant X1
kinesin family member 3A, transcript variant X2
RAD50 double strand break repair protein, transcript variant X4
RAD50 double strand break repair protein, transcript variant X1
RAD50 double strand break repair protein, transcript variant X3
RAD50 double strand break repair protein, transcript variant X2
INO80 complex subunit C-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
INO80 complex subunit C-like, transcript variant X1
INO80 complex subunit C-like, transcript variant X2
INO80 complex subunit C-like, transcript variant X4
prolyl 4-hydroxylase subunit alpha 2, transcript variant X1
prolyl 4-hydroxylase subunit alpha 2, transcript variant X5
prolyl 4-hydroxylase subunit alpha 2, transcript variant X4
prolyl 4-hydroxylase subunit alpha 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
prolyl 4-hydroxylase subunit alpha 2, transcript variant X3
prolyl 4-hydroxylase subunit alpha-2 isoform X1
prolyl 4-hydroxylase subunit alpha-2 isoform X2
solute carrier family 22 member 5-like, transcript variant X2
solute carrier family 22 member 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 22 member 5-like isoform X1
solute carrier family 22 member 5-like isoform X2
solute carrier family 22 member 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 22 member 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 22 member 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 22 member 4-like isoform X2
solute carrier family 22 member 4-like isoform X1
interferon regulatory factor 1, transcript variant X2
interferon regulatory factor 1, transcript variant X1
interferon regulatory factor 1, transcript variant X3
interferon regulatory factor 1 isoform X1
interferon regulatory factor 1 isoform X2
DND microRNA-mediated repression inhibitor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DND microRNA-mediated repression inhibitor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DND microRNA-mediated repression inhibitor 1, transcript variant X3
acyl-CoA synthetase long chain family member 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
meiosis-specific kinetochore protein-like, transcript variant X3
meiosis-specific kinetochore protein-like, transcript variant X6
meiosis-specific kinetochore protein-like, transcript variant X1
meiosis-specific kinetochore protein-like, transcript variant X2
meiosis-specific kinetochore protein-like, transcript variant X8
meiosis-specific kinetochore protein-like, transcript variant X4
meiosis-specific kinetochore protein-like, transcript variant X7
meiosis-specific kinetochore protein-like, transcript variant X5
meiosis-specific kinetochore protein-like isoform X1
meiosis-specific kinetochore protein-like isoform X2
uncharacterized protein LOC117351923 isoform X6
meiosis-specific kinetochore protein-like isoform X5
meiosis-specific kinetochore protein-like isoform X3
meiosis-specific kinetochore protein-like isoform X4
folliculin interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
folliculin interacting protein 1, transcript variant X4
folliculin interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
folliculin-interacting protein 1 isoform X1
folliculin-interacting protein 1 isoform X4
folliculin-interacting protein 1 isoform X2
folliculin interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
folliculin-interacting protein 1 isoform X3
Rap guanine nucleotide exchange factor 6, transcript variant X1
Rap guanine nucleotide exchange factor 6, transcript variant X5
Rap guanine nucleotide exchange factor 6, transcript variant X3
Rap guanine nucleotide exchange factor 6, transcript variant X2
Rap guanine nucleotide exchange factor 6, transcript variant X4
rap guanine nucleotide exchange factor 6 isoform X1
rap guanine nucleotide exchange factor 6 isoform X5
rap guanine nucleotide exchange factor 6 isoform X2
rap guanine nucleotide exchange factor 6 isoform X3
rap guanine nucleotide exchange factor 6 isoform X4
uncharacterized LOC117351496, transcript variant X2
uncharacterized LOC117351496, transcript variant X1
follistatin like 4, transcript variant X2
follistatin like 4, transcript variant X5
follistatin like 4, transcript variant X4
follistatin like 4, transcript variant X1
follistatin like 4, transcript variant X3
follistatin-related protein 4 isoform X3
follistatin-related protein 4 isoform X2
follistatin-related protein 4 isoform X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
keratinocyte-associated transmembrane protein 2
voltage dependent anion channel 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
voltage dependent anion channel 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
voltage-dependent anion-selective channel protein 1
transcription factor 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transcription factor 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transcription factor 7, transcript variant X3
transcription factor 7, transcript variant X6
transcription factor 7, transcript variant X4
transcription factor 7, transcript variant X5
transcription factor 7, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
S-phase kinase associated protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
S-phase kinase associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein phosphatase 2 catalytic subunit alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 71 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
cyclin dependent kinase like 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cyclin-dependent kinase-like 3 isoform X2
cyclin dependent kinase like 3, transcript variant X2
cyclin dependent kinase like 3, transcript variant X6
cyclin dependent kinase like 3, transcript variant X5
cyclin dependent kinase like 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cyclin dependent kinase like 3, transcript variant X1
cyclin-dependent kinase-like 3 isoform X5
cyclin-dependent kinase-like 3 isoform X4
cyclin-dependent kinase-like 3 isoform X3
cyclin-dependent kinase-like 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
CDKN2A interacting protein N-terminal like, transcript variant X2
CDKN2A interacting protein N-terminal like, transcript variant X1
CDKN2AIP N-terminal-like protein isoform X2
CDKN2AIP N-terminal-like protein isoform X1
jade family PHD finger 2, transcript variant X3
jade family PHD finger 2, transcript variant X2
jade family PHD finger 2, transcript variant X1
jade family PHD finger 2, transcript variant X4
E3 ubiquitin-protein ligase Jade-2 isoform X1
jade family PHD finger 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
E3 ubiquitin-protein ligase Jade-2 isoform X2
E3 ubiquitin-protein ligase Jade-2 isoform X3
secretion associated Ras related GTPase 1B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
SEC24 homolog A, COPII coat complex component
calcium modulating ligand, transcript variant X1
calcium modulating ligand, transcript variant X2
calcium signal-modulating cyclophilin ligand isoform X1
calcium signal-modulating cyclophilin ligand isoform X2
calcium modulating ligand, transcript variant X3
calcium signal-modulating cyclophilin ligand isoform X3
DEAD-box helicase 46, transcript variant X1
DEAD-box helicase 46, transcript variant X2
probable ATP-dependent RNA helicase DDX46 isoform X1
probable ATP-dependent RNA helicase DDX46 isoform X2
chromosome 18 C5orf24 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
chromosome 18 C5orf24 homolog, transcript variant X8
chromosome 18 C5orf24 homolog, transcript variant X10
chromosome 18 C5orf24 homolog, transcript variant X7
chromosome 18 C5orf24 homolog, transcript variant X5
chromosome 18 C5orf24 homolog, transcript variant X3
chromosome 18 C5orf24 homolog, transcript variant X2
chromosome 18 C5orf24 homolog, transcript variant X9
chromosome 18 C5orf24 homolog, transcript variant X4
chromosome 18 C5orf24 homolog, transcript variant X1
chromosome 18 C5orf24 homolog, transcript variant X12
chromosome 18 C5orf24 homolog, transcript variant X11
UPF0461 protein C5orf24 homolog isoform X2
UPF0461 protein C5orf24 homolog isoform X3
UPF0461 protein C5orf24 homolog isoform X4
UPF0461 protein C5orf24 homolog isoform X5
UPF0461 protein C5orf24 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
thioredoxin domain-containing protein 15
pterin-4 alpha-carbinolamine dehydratase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
pterin-4-alpha-carbinolamine dehydratase 2 isoform X1
pterin-4 alpha-carbinolamine dehydratase 2, transcript variant X3
pterin-4 alpha-carbinolamine dehydratase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pterin-4-alpha-carbinolamine dehydratase 2 isoform X2
pterin-4-alpha-carbinolamine dehydratase 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
core histone macro-H2A.1, transcript variant X3
core histone macro-H2A.1, transcript variant X1
core histone macro-H2A.1, transcript variant X5
core histone macro-H2A.1, transcript variant X4
core histone macro-H2A.1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
solute carrier family 25 member 48, transcript variant X4
solute carrier family 25 member 48, transcript variant X3
solute carrier family 25 member 48, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 25 member 48, transcript variant X1
solute carrier family 25 member 48, transcript variant X5
solute carrier family 25 member 48, transcript variant X6
solute carrier family 25 member 48 isoform X1
solute carrier family 25 member 48 isoform X2
F-box/LRR-repeat protein 21-like, transcript variant X1
F-box/LRR-repeat protein 21-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
F-box/LRR-repeat protein 21-like, transcript variant X3
F-box/LRR-repeat protein 21-like, transcript variant X4
F-box/LRR-repeat protein 21-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
F-box/LRR-repeat protein 21-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
F-box/LRR-repeat protein 21-like isoform X1
F-box/LRR-repeat protein 21-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transforming growth factor-beta-induced protein ig-h3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LOW QUALITY PROTEIN: mothers against decapentaplegic homolog 5
small integral membrane protein 32, transcript variant X2
small integral membrane protein 32, transcript variant X1
transient receptor potential cation channel subfamily C member 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
transient receptor potential cation channel subfamily C member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
transient receptor potential cation channel subfamily C member 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
short transient receptor potential channel 7 isoform X2
short transient receptor potential channel 7 isoform X1
short transient receptor potential channel 7 isoform X3
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1, transcript variant X4
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1, transcript variant X3
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
kelch-like protein 3, transcript variant X2
kelch-like protein 3, transcript variant X3
kelch-like protein 3, transcript variant X4
kelch-like protein 3, transcript variant X1
heterogeneous nuclear ribonucleoprotein A0
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
polycystin 2 like 2, transient receptor potential cation channel
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
polycystic kidney disease 2-like 2 protein
family with sequence similarity 13 member B, transcript variant X14
family with sequence similarity 13 member B, transcript variant X9
family with sequence similarity 13 member B, transcript variant X10
family with sequence similarity 13 member B, transcript variant X7
family with sequence similarity 13 member B, transcript variant X8
family with sequence similarity 13 member B, transcript variant X2
family with sequence similarity 13 member B, transcript variant X4
family with sequence similarity 13 member B, transcript variant X12
family with sequence similarity 13 member B, transcript variant X11
family with sequence similarity 13 member B, transcript variant X1
family with sequence similarity 13 member B, transcript variant X5
family with sequence similarity 13 member B, transcript variant X6
family with sequence similarity 13 member B, transcript variant X3
family with sequence similarity 13 member B, transcript variant X15
family with sequence similarity 13 member B, transcript variant X13
family with sequence similarity 13 member B, transcript variant X16
Wnt family member 8A, transcript variant X2
Wnt family member 8A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
NME/NM23 family member 5, transcript variant X1
NME/NM23 family member 5, transcript variant X2
nucleoside diphosphate kinase homolog 5 isoform X2
nucleoside diphosphate kinase homolog 5 isoform X1
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X1
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X5
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X6
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X3
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X7
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X2
heterogeneous nuclear ribonucleoprotein A/B isoform X1
heterogeneous nuclear ribonucleoprotein A/B isoform X2
5-phosphohydroxy-L-lysine phospho-lyase, transcript variant X2
5-phosphohydroxy-L-lysine phospho-lyase isoform X2
5-phosphohydroxy-L-lysine phospho-lyase, transcript variant X3
5-phosphohydroxy-L-lysine phospho-lyase, transcript variant X4
5-phosphohydroxy-L-lysine phospho-lyase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
5-phosphohydroxy-L-lysine phospho-lyase isoform X4
5-phosphohydroxy-L-lysine phospho-lyase isoform X1
5-phosphohydroxy-L-lysine phospho-lyase isoform X3
collagen type XXIII alpha 1 chain, transcript variant X3
collagen type XXIII alpha 1 chain, transcript variant X11
collagen type XXIII alpha 1 chain, transcript variant X6
collagen type XXIII alpha 1 chain, transcript variant X7
collagen type XXIII alpha 1 chain, transcript variant X8
collagen type XXIII alpha 1 chain, transcript variant X10
collagen type XXIII alpha 1 chain, transcript variant X9
collagen type XXIII alpha 1 chain, transcript variant X1
collagen type XXIII alpha 1 chain, transcript variant X5
collagen type XXIII alpha 1 chain, transcript variant X4
collagen type XXIII alpha 1 chain, transcript variant X2
collagen alpha-1(XXIII) chain isoform X3
collagen alpha-1(XXIII) chain isoform X11
collagen alpha-1(XXIII) chain isoform X6
collagen alpha-1(XXIII) chain isoform X7
collagen alpha-1(XXIII) chain isoform X8
collagen alpha-1(XXIII) chain isoform X1
collagen alpha-1(XXIII) chain isoform X2
collagen alpha-1(XXIII) chain isoform X10
collagen alpha-1(XXIII) chain isoform X5
collagen alpha-1(XXIII) chain isoform X9
collagen alpha-1(XXIII) chain isoform X4
CDC like kinase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
CDC like kinase 4, transcript variant X3
dual specificity protein kinase CLK4 isoform X1
dual specificity protein kinase CLK4 isoform X2
CDC like kinase 4, transcript variant X2
RasGEF domain family member 1C, transcript variant X3
RasGEF domain family member 1C, transcript variant X1
RasGEF domain family member 1C, transcript variant X2
ras-GEF domain-containing family member 1C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments
mitogen-activated protein kinase 9, transcript variant X3
mitogen-activated protein kinase 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X5
mitogen-activated protein kinase 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mitogen-activated protein kinase 9 isoform X1
mitogen-activated protein kinase 9 isoform X2
mitogen-activated protein kinase 9 isoform X4
mitogen-activated protein kinase 9 isoform X3
glutamine-fructose-6-phosphate transaminase 2, transcript variant X2
glutamine-fructose-6-phosphate transaminase 2, transcript variant X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 isoform X2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 isoform X1
CCR4-NOT transcription complex subunit 6, transcript variant X1
CCR4-NOT transcription complex subunit 6, transcript variant X2
CCR4-NOT transcription complex subunit 6 isoform X1
CCR4-NOT transcription complex subunit 6 isoform X2
CCR4-NOT transcription complex subunit 6, transcript variant X4
CCR4-NOT transcription complex subunit 6, transcript variant X3
CCR4-NOT transcription complex subunit 6 isoform X3
uncharacterized LOC117351659, transcript variant X1
uncharacterized LOC117351659, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 15-like, transcript variant X6
disintegrin and metalloproteinase domain-containing protein 15-like, transcript variant X4
disintegrin and metalloproteinase domain-containing protein 15-like, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 15-like, transcript variant X5
disintegrin and metalloproteinase domain-containing protein 15-like, transcript variant X3
disintegrin and metalloproteinase domain-containing protein 15-like, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 15-like isoform X6
disintegrin and metalloproteinase domain-containing protein 15-like isoform X4
disintegrin and metalloproteinase domain-containing protein 15-like isoform X2
disintegrin and metalloproteinase domain-containing protein 15-like isoform X5
disintegrin and metalloproteinase domain-containing protein 15-like isoform X3
disintegrin and metalloproteinase domain-containing protein 15-like isoform X1
uncharacterized LOC117351546, transcript variant X2
uncharacterized LOC117351546, transcript variant X1
uncharacterized LOC117351546, transcript variant X3
ADAM metallopeptidase with thrombospondin type 1 motif 2, transcript variant X1
ADAM metallopeptidase with thrombospondin type 1 motif 2, transcript variant X2
ADAM metallopeptidase with thrombospondin type 1 motif 2, transcript variant X5
ADAM metallopeptidase with thrombospondin type 1 motif 2, transcript variant X3
ADAM metallopeptidase with thrombospondin type 1 motif 2, transcript variant X4
A disintegrin and metalloproteinase with thrombospondin motifs 2 isoform X2
A disintegrin and metalloproteinase with thrombospondin motifs 2 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 2 isoform X3
ADAM metallopeptidase with thrombospondin type 1 motif 2, transcript variant X6
A disintegrin and metalloproteinase with thrombospondin motifs 2 isoform X4
eukaryotic translation initiation factor 4E-binding protein 3-like
ankyrin repeat and KH domain-containing protein 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ankyrin repeat and KH domain-containing protein 1-like
electrogenic sodium bicarbonate cotransporter 1-like, transcript variant X4
electrogenic sodium bicarbonate cotransporter 1-like, transcript variant X3
electrogenic sodium bicarbonate cotransporter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 1-like, transcript variant X1
electrogenic sodium bicarbonate cotransporter 1-like isoform X1
electrogenic sodium bicarbonate cotransporter 1-like isoform X2
electrogenic sodium bicarbonate cotransporter 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fatty acid binding protein 6, transcript variant X3
fatty acid binding protein 6, transcript variant X1
fatty acid binding protein 6, transcript variant X2
fatty acid binding protein 6, transcript variant X5
fatty acid binding protein 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
PWWP domain containing 2A, transcript variant X2
PWWP domain containing 2A, transcript variant X3
PWWP domain containing 2A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 43% coverage of the annotated genomic feature by RNAseq alignments
matrix metalloproteinase-21-like, transcript variant X2
matrix metalloproteinase-21-like, transcript variant X3
matrix metalloproteinase-21-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
matrix metalloproteinase-21-like isoform X1
matrix metalloproteinase-21-like isoform X2
ubiquitin like domain containing CTD phosphatase 1
ubiquitin-like domain-containing CTD phosphatase 1
ring finger protein 145, transcript variant X1
ring finger protein 145, transcript variant X2
EBF transcription factor 1, transcript variant X1
EBF transcription factor 1, transcript variant X4
EBF transcription factor 1, transcript variant X2
EBF transcription factor 1, transcript variant X5
EBF transcription factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
EBF transcription factor 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA threonine (anticodon UGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
clathrin interactor 1, transcript variant X3
clathrin interactor 1, transcript variant X1
clathrin interactor 1, transcript variant X2
U7 snRNA-associated Sm-like protein LSm11
tRNA-histidine guanylyltransferase 1 like, transcript variant X1
probable tRNA(His) guanylyltransferase isoform X1
tRNA-histidine guanylyltransferase 1 like, transcript variant X2
probable tRNA(His) guanylyltransferase isoform X2
disintegrin and metalloproteinase domain-containing protein 19
cytoplasmic FMR1 interacting protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cytoplasmic FMR1 interacting protein 2, transcript variant X2
cytoplasmic FMR1-interacting protein 2 isoform X2
cytoplasmic FMR1-interacting protein 2 isoform X1
IL2 inducible T cell kinase, transcript variant X2
IL2 inducible T cell kinase, transcript variant X1
IL2 inducible T cell kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
tyrosine-protein kinase ITK/TSK isoform X3
tyrosine-protein kinase ITK/TSK isoform X2
tyrosine-protein kinase ITK/TSK isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 7
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
hepatitis A virus cellular receptor 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
T-cell immunoglobulin and mucin domain-containing protein 4-like, transcript variant X1
T-cell immunoglobulin and mucin domain-containing protein 4-like, transcript variant X2
T-cell immunoglobulin and mucin domain-containing protein 4-like isoform X1
T-cell immunoglobulin and mucin domain-containing protein 4-like isoform X2
olfactory receptor class A-like protein 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: olfactory receptor class A-like protein 1
sarcoglycan delta, transcript variant X3
sarcoglycan delta, transcript variant X4
sarcoglycan delta, transcript variant X1
sarcoglycan delta, transcript variant X5
sarcoglycan delta, transcript variant X6
sarcoglycan delta, transcript variant X2
mitochondrial ribosomal protein L22, transcript variant X1
39S ribosomal protein L22, mitochondrial isoform X1
mitochondrial ribosomal protein L22, transcript variant X6
mitochondrial ribosomal protein L22, transcript variant X3
mitochondrial ribosomal protein L22, transcript variant X7
39S ribosomal protein L22, mitochondrial isoform X5
mitochondrial ribosomal protein L22, transcript variant X5
39S ribosomal protein L22, mitochondrial isoform X4
mitochondrial ribosomal protein L22, transcript variant X4
39S ribosomal protein L22, mitochondrial isoform X3
mitochondrial ribosomal protein L22, transcript variant X2
39S ribosomal protein L22, mitochondrial isoform X2
gem nuclear organelle associated protein 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 8, transcript variant X2
CCR4-NOT transcription complex subunit 8, transcript variant X1
CCR4-NOT transcription complex subunit 8, transcript variant X5
CCR4-NOT transcription complex subunit 8 isoform X1
CCR4-NOT transcription complex subunit 8 isoform X3
CCR4-NOT transcription complex subunit 8, transcript variant X4
CCR4-NOT transcription complex subunit 8, transcript variant X3
CCR4-NOT transcription complex subunit 8 isoform X2
fatty acid hydroxylase domain containing 2, transcript variant X1
fatty acid hydroxylase domain containing 2, transcript variant X2
fatty acid hydroxylase domain containing 2, transcript variant X4
fatty acid hydroxylase domain containing 2, transcript variant X3
fatty acid hydroxylase domain-containing protein 2
La ribonucleoprotein 1, translational regulator, transcript variant X1
La ribonucleoprotein 1, translational regulator, transcript variant X2
heart and neural crest derivatives expressed 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
heart- and neural crest derivatives-expressed protein 1
histone deacetylase complex subunit SAP30L
polypeptide N-acetylgalactosaminyltransferase 10, transcript variant X2
polypeptide N-acetylgalactosaminyltransferase 10, transcript variant X1
polypeptide N-acetylgalactosaminyltransferase 10, transcript variant X3
polypeptide N-acetylgalactosaminyltransferase 10, transcript variant X4
polypeptide N-acetylgalactosaminyltransferase 10 isoform X3
polypeptide N-acetylgalactosaminyltransferase 10 isoform X2
polypeptide N-acetylgalactosaminyltransferase 10 isoform X1
polypeptide N-acetylgalactosaminyltransferase 10 isoform X4
microfibril associated protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
microfibril associated protein 3, transcript variant X1
microfibril associated protein 3, transcript variant X2
family with sequence similarity 114 member A2, transcript variant X2
family with sequence similarity 114 member A2, transcript variant X1
family with sequence similarity 114 member A2, transcript variant X4
family with sequence similarity 114 member A2, transcript variant X3
LON peptidase N-terminal domain and RING finger protein 3-like, transcript variant X1
LON peptidase N-terminal domain and RING finger protein 3-like, transcript variant X4
LON peptidase N-terminal domain and RING finger protein 3-like, transcript variant X3
LON peptidase N-terminal domain and RING finger protein 3-like, transcript variant X2
LON peptidase N-terminal domain and RING finger protein 3-like isoform X1
LON peptidase N-terminal domain and RING finger protein 3-like isoform X2
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X4
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X3
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X7
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X9
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X1
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X2
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X5
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X6
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC117351918, transcript variant X1
uncharacterized LOC117351918, transcript variant X2
uncharacterized LOC117351918, transcript variant X3
probable serine/threonine-protein kinase nek3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: glycine receptor subunit alpha-1
G3BP stress granule assembly factor 1, transcript variant X2
G3BP stress granule assembly factor 1, transcript variant X1
G3BP stress granule assembly factor 1, transcript variant X3
G3BP stress granule assembly factor 1, transcript variant X4
ras GTPase-activating protein-binding protein 1
uncharacterized LOC117351721, transcript variant X2
uncharacterized LOC117351721, transcript variant X1
secreted protein acidic and cysteine rich, transcript variant X2
secreted protein acidic and cysteine rich, transcript variant X1
FAT atypical cadherin 2, transcript variant X2
FAT atypical cadherin 2, transcript variant X1
FAT atypical cadherin 2, transcript variant X3
proton-coupled amino acid transporter 1-like, transcript variant X1
proton-coupled amino acid transporter 1-like, transcript variant X2
proton-coupled amino acid transporter 1-like isoform X1
proton-coupled amino acid transporter 1-like isoform X2
proton-coupled amino acid transporter 1-like, transcript variant X3
proton-coupled amino acid transporter 1-like isoform X3
coiled-coil domain-containing protein 69
zona pellucida sperm-binding protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
TNFAIP3 interacting protein 1, transcript variant X1
TNFAIP3 interacting protein 1, transcript variant X2
TNFAIP3-interacting protein 1 isoform X1
TNFAIP3-interacting protein 1 isoform X2
protein NDNF-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein NDNF-like, transcript variant X1
small integral membrane protein 3, transcript variant X2
small integral membrane protein 3, transcript variant X1
RNA binding motif protein 22, transcript variant X1
pre-mRNA-splicing factor RBM22 isoform X1
RNA binding motif protein 22, transcript variant X2
pre-mRNA-splicing factor RBM22 isoform X2
N-deacetylase and N-sulfotransferase 1, transcript variant X2
N-deacetylase and N-sulfotransferase 1, transcript variant X1
N-deacetylase and N-sulfotransferase 1, transcript variant X4
N-deacetylase and N-sulfotransferase 1, transcript variant X3
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 isoform X1
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 isoform X2
uncharacterized LOC117351654, transcript variant X1
uncharacterized LOC117351654, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00089
COORDINATES: nucleotide motif:Rfam:12.0:RF00099
COORDINATES: nucleotide motif:Rfam:12.0:RF00088
COORDINATES: nucleotide motif:Rfam:12.0:RF00087
COORDINATES: nucleotide motif:Rfam:12.0:RF00070
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
HLA class II histocompatibility antigen gamma chain
treacle ribosome biogenesis factor 1, transcript variant X4
treacle ribosome biogenesis factor 1, transcript variant X7
treacle ribosome biogenesis factor 1, transcript variant X2
treacle ribosome biogenesis factor 1, transcript variant X6
treacle ribosome biogenesis factor 1, transcript variant X5
treacle ribosome biogenesis factor 1, transcript variant X1
treacle ribosome biogenesis factor 1, transcript variant X3
treacle ribosome biogenesis factor 1, transcript variant X9
treacle ribosome biogenesis factor 1, transcript variant X8
calcium/calmodulin dependent protein kinase II alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1
calcium/calmodulin dependent protein kinase II alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X2
solute carrier family 6 member 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 6 member 7, transcript variant X2
solute carrier family 6 member 7, transcript variant X3
sodium-dependent proline transporter isoform X1
sodium-dependent proline transporter isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
platelet derived growth factor receptor beta, transcript variant X1
platelet derived growth factor receptor beta, transcript variant X2
platelet derived growth factor receptor beta, transcript variant X3
platelet-derived growth factor receptor beta
colony stimulating factor 1 receptor, transcript variant X1
colony stimulating factor 1 receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
macrophage colony-stimulating factor 1 receptor isoform X1
macrophage colony-stimulating factor 1 receptor isoform X2
HMG-box containing 3, transcript variant X3
HMG-box containing 3, transcript variant X1
HMG-box containing 3, transcript variant X4
HMG-box containing 3, transcript variant X2
HMG domain-containing protein 3 isoform X1
HMG domain-containing protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
zinc-binding protein A33-like, transcript variant X3
zinc-binding protein A33-like, transcript variant X1
zinc-binding protein A33-like, transcript variant X2
zinc-binding protein A33-like isoform X1
E3 ubiquitin-protein ligase TRIM62-like isoform X3
zinc-binding protein A33-like isoform X2
fms related receptor tyrosine kinase 4, transcript variant X2
fms related receptor tyrosine kinase 4, transcript variant X1
vascular endothelial growth factor receptor 3 isoform X1
vascular endothelial growth factor receptor 3 isoform X2
fms related receptor tyrosine kinase 4, transcript variant X3
vascular endothelial growth factor receptor 3 isoform X3
ring finger protein 130, transcript variant X2
ring finger protein 130, transcript variant X3
ring finger protein 130, transcript variant X1
E3 ubiquitin-protein ligase RNF130 isoform X1
E3 ubiquitin-protein ligase RNF130 isoform X2
E3 ubiquitin-protein ligase RNF130 isoform X3
TBC1 domain family member 9B, transcript variant X1
TBC1 domain family member 9B, transcript variant X2
TBC1 domain family member 9B, transcript variant X3
MRN complex interacting protein, transcript variant X1
MRN complex interacting protein, transcript variant X2
MRN complex-interacting protein isoform X1
MRN complex-interacting protein isoform X2
transmembrane and coiled-coil domains 6, transcript variant X5
transmembrane and coiled-coil domains 6, transcript variant X2
transmembrane and coiled-coil domains 6, transcript variant X4
transmembrane and coiled-coil domains 6, transcript variant X3
transmembrane and coiled-coil domains 6, transcript variant X1
transmembrane and coiled-coil domain-containing protein 6 isoform X1
transmembrane and coiled-coil domain-containing protein 6 isoform X2
heterogeneous nuclear ribonucleoprotein H1, transcript variant X2
heterogeneous nuclear ribonucleoprotein H1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein H isoform X2
heterogeneous nuclear ribonucleoprotein H isoform X1
methionine adenosyltransferase 2 subunit beta
endothelial cell surface expressed chemotaxis and apoptosis regulator
endothelial cell-specific chemotaxis regulator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 23 member 1, transcript variant X4
solute carrier family 23 member 1, transcript variant X1
solute carrier family 23 member 1, transcript variant X2
solute carrier family 23 member 1, transcript variant X3
solute carrier family 23 member 1 isoform X2
solute carrier family 23 member 1 isoform X1
stimulator of interferon response cGAMP interactor 1
CXXC finger protein 5, transcript variant X9
CXXC finger protein 5, transcript variant X5
CXXC finger protein 5, transcript variant X4
CXXC finger protein 5, transcript variant X1
CXXC finger protein 5, transcript variant X2
CXXC finger protein 5, transcript variant X7
CXXC finger protein 5, transcript variant X6
CXXC finger protein 5, transcript variant X3
CXXC-type zinc finger protein 5 isoform X1
CXXC finger protein 5, transcript variant X8
CXXC-type zinc finger protein 5 isoform X2
ubiquitin conjugating enzyme E2 D2, transcript variant X4
ubiquitin conjugating enzyme E2 D2, transcript variant X5
ubiquitin conjugating enzyme E2 D2, transcript variant X2
ubiquitin conjugating enzyme E2 D2, transcript variant X1
ubiquitin conjugating enzyme E2 D2, transcript variant X7
ubiquitin conjugating enzyme E2 D2, transcript variant X8
ubiquitin conjugating enzyme E2 D2, transcript variant X10
ubiquitin conjugating enzyme E2 D2, transcript variant X9
ubiquitin conjugating enzyme E2 D2, transcript variant X6
ubiquitin conjugating enzyme E2 D2, transcript variant X11
ubiquitin-conjugating enzyme E2 D2 isoform X1
ubiquitin conjugating enzyme E2 D2, transcript variant X3
ubiquitin-conjugating enzyme E2 D2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcriptional activator protein Pur-alpha
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
RUN and FYVE domain containing 1, transcript variant X5
RUN and FYVE domain containing 1, transcript variant X7
RUN and FYVE domain containing 1, transcript variant X11
RUN and FYVE domain containing 1, transcript variant X6
RUN and FYVE domain containing 1, transcript variant X8
RUN and FYVE domain containing 1, transcript variant X1
RUN and FYVE domain containing 1, transcript variant X4
RUN and FYVE domain containing 1, transcript variant X2
RUN and FYVE domain containing 1, transcript variant X3
RUN and FYVE domain containing 1, transcript variant X16
RUN and FYVE domain-containing protein 1 isoform X4
RUN and FYVE domain-containing protein 1 isoform X7
RUN and FYVE domain-containing protein 1 isoform X3
RUN and FYVE domain-containing protein 1 isoform X5
RUN and FYVE domain-containing protein 1 isoform X1
RUN and FYVE domain-containing protein 1 isoform X11
RUN and FYVE domain-containing protein 1 isoform X2
RUN and FYVE domain containing 1, transcript variant X17
RUN and FYVE domain containing 1, transcript variant X18
RUN and FYVE domain containing 1, transcript variant X10
RUN and FYVE domain containing 1, transcript variant X19
RUN and FYVE domain containing 1, transcript variant X13
RUN and FYVE domain containing 1, transcript variant X14
RUN and FYVE domain-containing protein 1 isoform X9
RUN and FYVE domain containing 1, transcript variant X9
RUN and FYVE domain-containing protein 1 isoform X6
RUN and FYVE domain containing 1, transcript variant X15
RUN and FYVE domain-containing protein 1 isoform X10
RUN and FYVE domain containing 1, transcript variant X12
RUN and FYVE domain-containing protein 1 isoform X8
dynein regulatory complex protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
proheparin-binding EGF-like growth factor
dedicator of cytokinesis 2, transcript variant X2
poly(A) binding protein interacting protein 2, transcript variant X3
poly(A) binding protein interacting protein 2, transcript variant X6
poly(A) binding protein interacting protein 2, transcript variant X1
poly(A) binding protein interacting protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
poly(A) binding protein interacting protein 2, transcript variant X4
polyadenylate-binding protein-interacting protein 2 isoform X1
polyadenylate-binding protein-interacting protein 2 isoform X3
poly(A) binding protein interacting protein 2, transcript variant X2
polyadenylate-binding protein-interacting protein 2 isoform X2
dedicator of cytokinesis 2, transcript variant X5
dedicator of cytokinesis 2, transcript variant X4
dedicator of cytokinesis 2, transcript variant X1
dedicator of cytokinesis 2, transcript variant X3
dedicator of cytokinesis protein 2 isoform X4
dedicator of cytokinesis protein 2 isoform X3
dedicator of cytokinesis protein 2 isoform X1
dedicator of cytokinesis protein 2 isoform X2
uncharacterized LOC117351778, transcript variant X2
uncharacterized LOC117351778, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments
lymphocyte cytosolic protein 2, transcript variant X2
lymphocyte cytosolic protein 2, transcript variant X1
lymphocyte cytosolic protein 2 isoform X2
lymphocyte cytosolic protein 2 isoform X1
potassium voltage-gated channel interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Kv channel-interacting protein 1 isoform X1
potassium voltage-gated channel interacting protein 1, transcript variant X5
potassium calcium-activated channel subfamily M regulatory beta subunit 1, transcript variant X1
potassium calcium-activated channel subfamily M regulatory beta subunit 1, transcript variant X2
potassium calcium-activated channel subfamily M regulatory beta subunit 1, transcript variant X4
potassium calcium-activated channel subfamily M regulatory beta subunit 1, transcript variant X3
calcium-activated potassium channel subunit beta-1
potassium voltage-gated channel interacting protein 1, transcript variant X4
double-strand-break repair protein rad21-like protein 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: double-strand-break repair protein rad21-like protein 1
potassium voltage-gated channel interacting protein 1, transcript variant X3
potassium voltage-gated channel interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Kv channel-interacting protein 1 isoform X2
Kv channel-interacting protein 1 isoform X3
Kv channel-interacting protein 1 isoform X4
RAN binding protein 17, transcript variant X1
RAN binding protein 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
fibroblast growth factor 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
fibroblast growth factor 18, transcript variant X1
fibroblast growth factor 18, transcript variant X3
F-box and WD repeat domain containing 11, transcript variant X2
F-box and WD repeat domain containing 11, transcript variant X6
F-box and WD repeat domain containing 11, transcript variant X5
F-box and WD repeat domain containing 11, transcript variant X4
F-box and WD repeat domain containing 11, transcript variant X1
F-box and WD repeat domain containing 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
F-box/WD repeat-containing protein 11 isoform X4
F-box/WD repeat-containing protein 11 isoform X2
F-box/WD repeat-containing protein 11 isoform X3
F-box/WD repeat-containing protein 11 isoform X1
F-box/WD repeat-containing protein 11 isoform X5
eukaryotic translation termination factor 1
eukaryotic peptide chain release factor subunit 1
heat shock protein family A (Hsp70) member 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00154
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
leucine rich repeat transmembrane neuronal 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat transmembrane neuronal protein 2
SIL1 nucleotide exchange factor, transcript variant X4
SIL1 nucleotide exchange factor, transcript variant X2
SIL1 nucleotide exchange factor, transcript variant X1
SIL1 nucleotide exchange factor, transcript variant X3
SIL1 nucleotide exchange factor, transcript variant X5
nucleotide exchange factor SIL1 isoform X1
nucleotide exchange factor SIL1 isoform X2
pantothenate kinase 3, transcript variant X1
pantothenate kinase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
proton-coupled amino acid transporter 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
rho GTPase-activating protein 7-like, transcript variant X1
rho GTPase-activating protein 7-like isoform X1
rho GTPase-activating protein 7-like, transcript variant X3
rho GTPase-activating protein 7-like isoform X3
rho GTPase-activating protein 7-like, transcript variant X2
rho GTPase-activating protein 7-like isoform X2
arginyl-tRNA synthetase 1, transcript variant X3
arginyl-tRNA synthetase 1, transcript variant X1
arginyl-tRNA synthetase 1, transcript variant X2
arginine--tRNA ligase, cytoplasmic isoform X2
arginine--tRNA ligase, cytoplasmic isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
teneurin transmembrane protein 2, transcript variant X2
teneurin transmembrane protein 2, transcript variant X1
teneurin transmembrane protein 2, transcript variant X3
teneurin transmembrane protein 2, transcript variant X4
piggyBac transposable element-derived protein 4-like
uncharacterized LOC117351512, transcript variant X2
uncharacterized LOC117351512, transcript variant X1
gamma-aminobutyric acid type A receptor subunit gamma2, transcript variant X1
gamma-aminobutyric acid type A receptor subunit gamma2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid type A receptor subunit gamma2, transcript variant X2
gamma-aminobutyric acid receptor subunit gamma-2
gamma-aminobutyric acid receptor subunit alpha-1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid receptor subunit alpha-1, transcript variant X3
gamma-aminobutyric acid receptor subunit alpha-1, transcript variant X2
gamma-aminobutyric acid receptor subunit alpha-1 isoform X1
gamma-aminobutyric acid receptor subunit alpha-1 isoform X2
gamma-aminobutyric acid type A receptor subunit beta2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid type A receptor subunit beta2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid type A receptor subunit beta2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid receptor subunit beta-2 isoform X3
gamma-aminobutyric acid receptor subunit beta-2 isoform X1
gamma-aminobutyric acid receptor subunit beta-2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ATPase phospholipid transporting 10B (putative), transcript variant X1
ATPase phospholipid transporting 10B (putative), transcript variant X2
probable phospholipid-transporting ATPase VB
PTTG1 regulator of sister chromatid separation, securin, transcript variant X2
PTTG1 regulator of sister chromatid separation, securin, transcript variant X1
PTTG1 regulator of sister chromatid separation, securin, transcript variant X3
PTTG1 regulator of sister chromatid separation, securin, transcript variant X4
SLU7 homolog, splicing factor, transcript variant X1
SLU7 homolog, splicing factor, transcript variant X3
SLU7 homolog, splicing factor, transcript variant X2
pre-mRNA-splicing factor SLU7 isoform X3
pre-mRNA-splicing factor SLU7 isoform X2
pre-mRNA-splicing factor SLU7 isoform X1
complement C1q tumor necrosis factor-related protein 2
amyloid beta precursor protein binding family B member 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: amyloid-beta A4 precursor protein-binding family B member 3
solute carrier family 35 member A4, transcript variant X1
SLC35A4 upstream open reading frame protein-like
solute carrier family 35 member A4, transcript variant X2
solute carrier family 35 member A4, transcript variant X3
probable UDP-sugar transporter protein SLC35A4
osmotic avoidance abnormal protein 3-like, transcript variant X1
osmotic avoidance abnormal protein 3-like, transcript variant X2
osmotic avoidance abnormal protein 3-like isoform X1
osmotic avoidance abnormal protein 3-like isoform X2
osmotic avoidance abnormal protein 3-like, transcript variant X3
osmotic avoidance abnormal protein 3-like, transcript variant X4
osmotic avoidance abnormal protein 3-like isoform X3
NADH:ubiquinone oxidoreductase subunit A2, transcript variant X2
NADH:ubiquinone oxidoreductase subunit A2, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 isoform X2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 isoform X1
histidine--tRNA ligase, cytoplasmic-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
histidine--tRNA ligase, cytoplasmic-like, transcript variant X2
histidine--tRNA ligase, cytoplasmic-like isoform X1
histidine--tRNA ligase, cytoplasmic-like isoform X2
histidine--tRNA ligase, cytoplasmic-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
histidine--tRNA ligase, cytoplasmic-like isoform X3
H/ACA ribonucleoprotein complex subunit 2
zinc finger matrin-type 2, transcript variant X1
zinc finger matrin-type 2, transcript variant X2
zinc finger matrin-type protein 2 isoform X1
zinc finger matrin-type protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71 Proteins, and 2% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 22% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
protocadherin alpha-C2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 126 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protocadherin alpha-C2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 229 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
protocadherin alpha-C2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 156 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
protocadherin alpha-C2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 116 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
protocadherin beta 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protocadherin beta 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protocadherin beta 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 123 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 145 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 106 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 403 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 124 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protocadherin gamma-C3
diaphanous related formin 1, transcript variant X2
diaphanous related formin 1, transcript variant X1
FCH and double SH3 domains 1, transcript variant X3
FCH and double SH3 domains 1, transcript variant X2
FCH and double SH3 domains 1, transcript variant X1
FCH and double SH3 domains 1, transcript variant X4
FCH and double SH3 domains 1, transcript variant X5
F-BAR and double SH3 domains protein 1 isoform X1
F-BAR and double SH3 domains protein 1 isoform X3
F-BAR and double SH3 domains protein 1 isoform X4
F-BAR and double SH3 domains protein 1 isoform X2
FCH and double SH3 domains 1, transcript variant X6
F-BAR and double SH3 domains protein 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X3
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X4
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X6
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X1
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X5
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X2
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X2
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X1
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X7
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 45% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC117351897, transcript variant X2
uncharacterized LOC117351897, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase- like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mastermind like transcriptional coactivator 1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B
COORDINATES: nucleotide motif:Rfam:12.0:RF00004